| abstract |
Disclosed herein is a single chain variable fragment CD3 binding protein with improved binding affinity and robust aggregation profile. In addition, multispecific binding proteins including single chain variable fragment CD3 binding proteins according to the present disclosure are also described. Pharmaceutical compositions comprising the binding proteins disclosed herein and methods of using such formulations are provided. [Selection] Figure 1 |